Alpine Woods Capital Investors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
O
IC
Alpine Woods Capital Investors's LKFT Position: Q1 2021 in Review
Alpine Woods Capital Investors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 25,563 shares — an estimated $2.53M sold.
Alpine Woods Capital Investors first reported a position in LKFT in Q3 2020 and held it in 2 quarters. The position peaked at $2.73M in Q3 2020. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.
- Alpine Woods Capital Investors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
- Alpine Woods Capital Investors sold 25,563 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $2.53M.
- Alpine Woods Capital Investors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2020 and held it in 2 quarters.
- Alpine Woods Capital Investors's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.73M in Q3 2020.
- 132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.
Based on Alpine Woods Capital Investors's 13F filing for Q1 2021, filed 11 May 2021.